New Diaryl-1,2,4-triazolo[3,4-
Journal
ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658
Informations de publication
Date de publication:
06 Aug 2024
06 Aug 2024
Historique:
received:
26
01
2024
revised:
24
04
2024
accepted:
13
05
2024
medline:
12
8
2024
pubmed:
12
8
2024
entrez:
12
8
2024
Statut:
epublish
Résumé
COX-2-selective drugs were withdrawn from the market just a few years after their development due to cardiovascular side effects. As a result, developing a selective COX-2 inhibitor as an anti-inflammatory agent with cardioprotective characteristics has become a prominent objective in medicinal chemistry. New 15 diaryl-1,2,4-triazolo[3,4-
Identifiants
pubmed: 39130606
doi: 10.1021/acsomega.4c00870
pmc: PMC11307993
doi:
Types de publication
Journal Article
Langues
eng
Pagination
33494-33509Informations de copyright
© 2024 The Authors. Published by American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare no competing financial interest.